Page 1 | Search Results | Hematology, ASH Education Program

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients

Sergio Giralt, Eric Seifter

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 103–109.

https://doi.org/10.1182/asheducation-2018.1.103

Published: 2018

Journal Articles

Management of multiple myeloma in the newly diagnosed patient

María-Victoria Mateos, Jesús F. San Miguel

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 498–507.

https://doi.org/10.1182/asheducation-2017.1.498

Published: 2017

Journal Articles

Management of multiple myeloma in the relapsed/refractory patient

Pieter Sonneveld

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 508–517.

https://doi.org/10.1182/asheducation-2017.1.508

Published: 2017

Journal Articles

Emerging options in multiple myeloma: targeted, immune, and epigenetic therapies

Shaji Kumar

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 518–524.

https://doi.org/10.1182/asheducation-2017.1.518

Published: 2017

Journal Articles

Toward personalized treatment in Waldenström macroglobulinemia

Jorge J. Castillo, Steven P. Treon

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 365–370.

https://doi.org/10.1182/asheducation-2017.1.365

Published: 2017

Journal Articles

Sequencing of nontransplant treatments in multiple myeloma patients with active disease

Andrew J. Yee, Noopur S. Raje

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 495–503.

https://doi.org/10.1182/asheducation-2016.1.495

Published: 2016

Journal Articles

Multiple myeloma: a model for scientific and clinical progress

Jesus San Miguel

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 1–7.

https://doi.org/10.1182/asheducation-2014.1.1

Published: 2014

Journal Articles

How should we treat newly diagnosed multiple myeloma patients?

María-Victoria Mateos, Jesús F. San Miguel

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 488–495.

https://doi.org/10.1182/asheducation-2013.1.488

Published: 2013

Journal Articles

Transplantation for mantle cell lymphoma: is it the right thing to do?

Michael E. Williams

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 568–574.

https://doi.org/10.1182/asheducation-2013.1.568

Published: 2013

Journal Articles

Have drug combinations supplanted stem cell transplantation in myeloma?

Antonio Palumbo, Federica Cavallo

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 335–341.

https://doi.org/10.1182/asheducation.V2012.1.335.3792205

Published: 2012

Journal Articles

New Insights into Therapeutic Targets in Myeloma

Kenneth C. Anderson

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 184–190.

https://doi.org/10.1182/asheducation-2011.1.184

Published: 2011

Journal Articles

Systemic Light-Chain Amyloidosis: Advances in Diagnosis, Prognosis, and Therapy

Adam D. Cohen, Raymond L. Comenzo

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 287–294.

https://doi.org/10.1182/asheducation-2010.1.287

Published: 2010

Journal Articles

Dealing with Neuropathy in Plasma-Cell Dyscrasias

Pieter Sonneveld, Joost L.M. Jongen

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 423–430.

https://doi.org/10.1182/asheducation-2010.1.423

Published: 2010

Journal Articles

Current treatment standards and emerging strategies in mantle cell lymphoma

Martin Dreyling, Wolfgang Hiddemann, for The European MCL Network

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 542–551.

https://doi.org/10.1182/asheducation-2009.1.542

Published: 2009

Journal Articles

Novel therapies for relapsed myeloma

A. Keith Stewart

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 578–586.

https://doi.org/10.1182/asheducation-2009.1.578

Published: 2009

Journal Articles

Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways

Owen A. O’Connor

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 270–276.

https://doi.org/10.1182/asheducation-2007.1.270

Published: 2007

Journal Articles

The Ubiquitin Proteasome Pathway from Bench to Bedside

Robert Z. Orlowski

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 220–225.

https://doi.org/10.1182/asheducation-2005.1.220

Published: 2005

NARROW

Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients

Management of multiple myeloma in the newly diagnosed patient

Management of multiple myeloma in the relapsed/refractory patient

Emerging options in multiple myeloma: targeted, immune, and epigenetic therapies

Toward personalized treatment in Waldenström macroglobulinemia

Sequencing of nontransplant treatments in multiple myeloma patients with active disease

Multiple myeloma: a model for scientific and clinical progress

How should we treat newly diagnosed multiple myeloma patients?

Transplantation for mantle cell lymphoma: is it the right thing to do?

Have drug combinations supplanted stem cell transplantation in myeloma?

New Insights into Therapeutic Targets in Myeloma

Systemic Light-Chain Amyloidosis: Advances in Diagnosis, Prognosis, and Therapy

Dealing with Neuropathy in Plasma-Cell Dyscrasias

Current treatment standards and emerging strategies in mantle cell lymphoma

Novel therapies for relapsed myeloma

Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways

The Ubiquitin Proteasome Pathway from Bench to Bedside

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only